Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI

NCT00546260 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

70

Enrollment

INDUSTRY

Sponsor class

Stopped Administrative reasons.

Conditions

Myocardial Infarction

Interventions

DRUG: placebo
DRUG: PRT060128 Potassium

Sponsor

Portola Pharmaceuticals